In multivessel coronary artery disease, a "state-of-the-art" randomized clinical trial of revascularization is needed

• Published in: Catheterization and cardiovascular interventions Vol. 87; no. 1; pp. 13 - 14
• Main Authors: Bang, Vigyan V., Levy, Michael S.
• Format: Journal Article
• Language: English
• Published: United States Blackwell Publishing Ltd 01-01-2016; Wiley Subscription Services, Inc
• Subjects: Angioplasty; Cardiovascular disease; Clinical outcomes; Coronary Artery Disease - surgery; Coronary vessels; Health risk assessment; Humans; Myocardial Revascularization - standards; Practice Guidelines as Topic; Randomized Controlled Trials as Topic
• ISSN: 1522-1946; 1522-726X
• DOI: 10.1002/ccd.26384

Key Points
Based on this meta‐analysis of primarily observational data, complete revascularization (CR) is associated with a reduced risk of death, MI, and repeat revascularization in patients with multivessel coronary artery disease (MVCAD) as compared with incomplete revascularization (IR).
Given the current state of evidence, the likelihood of achieving complete revascularization should influence whether PCI or CABG is the best strategy in patients with MVCAD.
Given the lack of randomized trials in this area, more robust trial data will address the validity of these findings.